Rallybio Corporation — movimiento trimestral de fondos (NASDAQ:RLYB) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 68.11 M57.98 M51 M67.66 M62.26 M Total de pasivos 6.45 M3.91 M5.04 M4.63 M4.3 M Capital total 61.65 M54.07 M45.96 M63.03 M57.96 M Total de pasivos y patrimonio neto 68.11 M57.98 M51 M67.66 M62.26 M Deuda total ————— Deuda neta —————

Noticias

El director médico de Rallybio se marcha tras anuncio de cambio de liderazgo

Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript

Rallybio adquirirá Candid Therapeutics en acuerdo de 505 millones

Rallybio to acquire Candid Therapeutics in $505M deal

Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism - Rallybio (NASDAQ:RLYB)

Lieber, director financiero de Rallybio, vende acciones por 3.992 dólares

CFO de Rallybio vende acciones por $3,992

Lieber, Rallybio CFO, sells $3992 in shares

Rallybio reports positive phase 1 results for subcutaneous C5 inhibitor

Rallybio announces one-for-eight reverse stock split effective Feb 6

Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested - TipRanks.com

Rallybio implementará un split inverso de acciones de 1 por 8 a partir del 6 de febrero